9 Meters Biopharma is a gastrointestinal platform company developing targeted therapies for patients with rare gastrointestinal disorders, focusing on conditions that currently lack effective treatment options. By utilizing advanced drug delivery systems and biologics, the company aims to improve patient outcomes and address significant unmet medical needs in this specialized area.
Funding
Funding not disclosed
Founders
Product
Problem
Patients with rare gastrointestinal disorders often lack effective treatment options, leading to significant unmet medical needs. Current therapies may not be targeted or may have limited efficacy in addressing these specialized conditions.
Solution
9 Meters Biopharma is developing targeted therapies for rare gastrointestinal disorders. The company focuses on utilizing advanced drug delivery systems and biologics to improve patient outcomes. By addressing conditions that currently lack effective treatment options, 9 Meters Biopharma aims to provide specialized solutions for patients with these challenging disorders. The company's gastrointestinal platform is designed to deliver precise and effective treatments, filling a critical gap in the market.
Target Audience
The primary target audience includes patients with rare gastrointestinal disorders and the healthcare providers who treat them.
Features
- Advanced drug delivery systems for targeted treatment
- Focus on biologics for improved efficacy
- Development of therapies for rare gastrointestinal disorders
- Addressing conditions with limited or no existing treatment options